Former FDA leaders, pharma speak out on mifepristone

๐ŸŒ statnews.com —
Former FDA leaders, pharma speak out on mifepristone

AI Summary

Former FDA leaders and pharmaceutical industry representatives have voiced concerns regarding the abortion drug mifepristone amid ongoing legal challenges. Their statements highlight the impact of restrictions on pharmaceutical accessibility and health policy.

Politics Health FDA mifepristone pharmaceutical health policy legal challenges

Read original source →